Drug Evaluation Committee Drug Development Utilizing Patients' Voices Patient Centricity by Pharmaceutical Companies
Clinical Evaluation Subcommittee
September 2019
The Clinical Evaluation Subcommittee has been working on the theme of "Patient Centricity" since FY2016, aiming to develop drugs in cooperation with patients. In FY2017, the third year of the project, we compiled the following report.
Patient Centricity in Drug Development
In FY 2018, the third year of the project, we prepared two reports to further promote the implementation of Patient Centricity-based activities in each company. The second is a report on how to communicate with patient groups at each stage of collaboration, based on the knowledge and experience gained by the task force to date.
The ultimate goal of the Task Force is the implementation of patient-initiated drug development in all pharmaceutical companies. We hope that both guidebooks will assist companies in implementing Patient Centricity activities.
Deliverables of the Drug Evaluation Committee Return to list of all deliverables